Länder Analysen: Schweiz
| 06.02.26 | UBS Underweight | Barclays Capital | |
| 06.02.26 | Novartis Neutral | UBS AG | |
| 06.02.26 | UBS Neutral | Goldman Sachs Group Inc. | |
| 06.02.26 | Nestlé Neutral | UBS AG | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | UBS Buy | Deutsche Bank AG | |
| 05.02.26 | Novartis Buy | Deutsche Bank AG | |
| 05.02.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 04.02.26 | Givaudan Halten | DZ BANK | |
| 04.02.26 | UBS Buy | Jefferies & Company Inc. | |
| 04.02.26 | UBS Outperform | RBC Capital Markets | |
| 04.02.26 | Novartis Neutral | UBS AG | |
| 04.02.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 04.02.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | UBS Underweight | Barclays Capital | |
| 04.02.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.02.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | UBS Buy | Goldman Sachs Group Inc. | |
| 02.02.26 | Roche Hold | Deutsche Bank AG | |
| 02.02.26 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 02.02.26 | Roche Kaufen | DZ BANK | |
| 02.02.26 | Roche Underperform | Jefferies & Company Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 30.01.26 | Givaudan Neutral | UBS AG | |
| 30.01.26 | Roche Buy | UBS AG | |
| 30.01.26 | Swiss Re Underweight | Barclays Capital | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 30.01.26 | Givaudan Overweight | Barclays Capital | |
| 30.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 30.01.26 | Givaudan Buy | Deutsche Bank AG | |
| 30.01.26 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 30.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 30.01.26 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 29.01.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 29.01.26 | Roche Outperform | Bernstein Research | |
| 29.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 29.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 29.01.26 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 29.01.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Givaudan Neutral | UBS AG | |
| 29.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 29.01.26 | Roche Underperform | Jefferies & Company Inc. | |
| 29.01.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 28.01.26 | Roche Hold | Deutsche Bank AG | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 27.01.26 | Roche Underperform | Jefferies & Company Inc. | |